Codiak BioSciences Inc. (CDAK) Social Stream



Codiak BioSciences Inc. (CDAK): $0.77

0.06 (+8.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CDAK to Watchlist
Sign Up

Industry: Biotech


Ranked

of 394

in industry

CODIAK BIOSCIENCES INC (CDAK) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CODIAK BIOSCIENCES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 2 $34 $34 $34 $0.608 5492.11%
2022-02-22 2 $24 $24 $24 $0.608 3847.37%
2022-05-06 2 $17 $17 $17 $0.608 2696.05%
2022-05-24 3 $17 $8 $12.5 $0.608 1955.92%
2022-07-05 3 $17 $7 $12 $0.608 1873.68%
2022-08-05 3 $9 $7 $8 $0.608 1215.79%
2022-11-04 3 $7 $2 $4.5 $0.608 640.13%
2022-11-07 3 $7 $1.4 $4.2 $0.608 590.79%

The Trend in the Analyst Price Target


Over the past 14 months, CDAK's average price target has gone down $32.47.

Over the past 37 weeks, CDAK's average upside potential has been 400.95%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-22 2 24 24 24.0 4.84 395.87%
2022-05-06 2 17 17 17.0 2.89 488.24%
2022-05-06 3 17 17 17.0 2.89 488.24%
2022-09-01 3 7 2 4.5 1.74 158.62%
2022-11-04 3 7 2 4.5 0.72 525%

CDAK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


CDAK's average broker recommendation rating worsened by 0.67 over the prior 39 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, CODIAK BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 981.14% of them.
  • In terms of how CODIAK BIOSCIENCES INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 73.03% of that group.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, CODIAK BIOSCIENCES INC's variance in analysts' estimates is lower than -287.91% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, CODIAK BIOSCIENCES INC's average analyst price target is greater than 258.33% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CODIAK BIOSCIENCES INC are OPT, TARS, and ALGS.

Is CDAK a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5815 seconds.